Ireland[爱尔兰药品]

AMMONAPS 500 mg tablets.Sodium Phenylbutyrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-08 　查阅全文...

AMMONAPS 940 mg/g granulesSodium Phenylbutyrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-08 　查阅全文...

Xalkori 200mg and 250mg hard capsule

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-08 　查阅全文...

Abraxane 5 mg/ml powder for suspension for infusion.Paclitax

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2..

录入者：admin 发表于：2014-02-06 　查阅全文...

XGEVA 120 mg solution for injectionDenosumab

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-06 　查阅全文...

Noxafil 40 mg/ml oral suspensionPosaconazole

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2..

录入者：admin 发表于：2014-02-06 　查阅全文...

Nexavar 200 mg film-coated tabletsSorafenib tosilate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

Kuvan 100 mg soluble tabletsSapropterin Dihydrochloride

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

Orfadin 5 mg hard capsulesNitisinone

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

Orfadin 2 mg hard capsulesNitisinone

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

Orfadin 10 mg hard capsulesNitisinone

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

Ilaris 150mg powder for solution for injection

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

AMMONAPS 500 mg tablets.Sodium Phenylbutyrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

AMMONAPS 940 mg/g granulesSodium Phenylbutyrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-28 　查阅全文...

Rebetol 200mg hard capsules

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-01-24 　查阅全文...

Amlodipine 10 mg tablets

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-19 　查阅全文...

Flolan 0.5 mg Powder and Solvent for Solution for Infusion

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-17 　查阅全文...

Demeclocycline Hydrochloride 150mg Capsules

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-17 　查阅全文...

Fabrazyme 35 mg powder for concentrate for solution for infu

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-15 　查阅全文...

Fabrazyme 5 mg powder for concentrate for solution for infus

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-01-15 　查阅全文...

首页上一页 55 56 57 58 59 60 61 下一页尾页 58/66/1301